Moderna’s CEO on Wednesday defended a plan to more than quadruple the company’s COVID-19 vaccine price, but he also said the drugmaker will work to ensure patients continue paying nothing at ...

The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...

Pfizer and Moderna say their work on their blockbuster Covid vaccines is ... length of the mRNA strand in the vaccine, according to Burton. The shot could increase the number of vaccine ...

Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is ...

Protesters gathered Wednesday afternoon outside the Beacon Hill home of the Moderna CEO Stéphane Bancel, calling on the company to make the technology behind its COVID-19 vaccine ... capacity to ...

Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers. COVID-19 ...

The company reaffirmed its forecast of $13.5 billion in Covid vaccine sales in 2023 and $8 billion in revenue for Paxlovid. Pfizer CEO Albert Bourla ... The company said the increase was also ...

COVID arm is a harmless delayed skin reaction to the COVID vaccine. It happens about one week after the first or second shot of the Moderna vaccine but may also occur after Pfizer. If you didn’t ...

What is the risk of stroke after the COVID-19 vaccine? Researchers have continued to study stroke risk after COVID-19 vaccination. So far, many have found that there’s no increase in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

With an underused COVID-19 as vaccine its lone product, Novavax said earlier this year it may not be able to stay solvent and ...